chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID infection; Covid infection; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 66-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 5 (booster), single (Lot number: GJ6742) at the age of 66 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 22Feb2021 as dose 1, single (Lot number: EL3247), in left arm, on 15Mar2021 as dose 2, single (Lot number: EL3247), in left arm, on 01Sep2021 as dose 3 (booster), single (Lot number: FF2589), in left arm and on 05Apr2022 as dose 4 (booster), single (Lot number: EL3247), in left arm for covid-19 immunisation. The patient's relevant medical history included: "hypertension" (unspecified if ongoing), notes: Other medical history: Hypertension, asthma; "asthma" (unspecified if ongoing). Concomitant medication(s) included: LIPTOR [ATORVASTATIN]; CHLORTHALIDONE; KCL; VIT C; VITAMIN B12 [VITAMIN B12 NOS]; and multivitamins. Past drug history included: Mucinex, reaction(s): "Known allergy: Mucinex", notes: Known allergy: Mucinex.  The following information was reported: VACCINATION FAILURE (medically significant) with onset 08Jan2023, outcome "recovering", described as "COVID infection"; COVID-19 (medically significant) with onset 08Jan2023, outcome "recovering", described as "Covid infection". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (08Jan2023) Positive, notes: Nasal Swab. Therapeutic measures were taken as a result of vaccination failure and covid-19 which included Paxlovid.; Sender's Comments: The reported COVID-19 positive after company products immunization is considered ineffective of products, and the Company cannot completely exclude the possible causality between the reported events and the product administration
From telephone contact received on 8/7/02, it was reported that a 39 year old female received a dose of TD vaccine on 8/5/02. Within 24 hours, patient developed pain and swelling at injection site, left chest pain, neck pain, redness and stiffness and puffiness of face, and fever of 102 degrees F. Patient was seen at the hospital 2 times and unresolved.
approx 3 hrs p/recvd vax pt began w/crying & screaming; mom states it lasted x 5-6 hrs; mom called clinic & was adivsed to call MD if it lasted more than 3 hrs; states did & was told nothing could be done; pt leg was swollen x 3 wks; t101.9
I had a routine mammogram 15OCT2022 after that I got a call for a need to go have a biopsy as small calcifications was noted in my left breast. The biopsy showed cancer.
Cellulitis on right UE started 24 hours after vaccine administration. No fever. Treatment: abx
Developed erythema and induration of skin by evening on day given. Was limping yesterday. No treatment provided at home. Recommended ibuprofen, BENADRYL, heat packs until resolves.
Fever 101.5, severe headache, dizziness, blurred vision, GI symptoms, body pain.
pt recv vax 22NOV96 & 7DEC96 pt devel a sore throat & was treated w/ATB;sore throat abated;pt devel sniffles & was not sure if it was allergies or a cold;
Rash over entirety of body that feels hot. Relatively unresponsive to antihistamines.
Lumps in arm raised and itchy.purple at injection site. and still is a large discolored area on my arm after two weeks
I started getting symptoms of fever, night sweats, cough, and sore throat. I took an at home COVID-19 test that was positive. I contacted my doctor and was prescribed Paxlovid. I took Paxlovid for 5 days. During the time course I had fatigue. I don't feel like the Paxlovid helped with they symptoms. I had prolonged COVID-19 and tested positive for 2 weeks. I did also have a persistent cough. I went to get an allergy test on 7/13/2022 and was unable to get testing because none of the controls reacted. I have to be scheduled back to get an allergy test. I'm not for sure if the reason why is because of Paxlovid or COVID-19. I do not have any symptoms now except for some fatigue.
"  Patient's left arm had been sore with a red circle around the injection site for a couple of days since her second Moderna vaccine on 2/26/21.  After the initial pain and redness went away, a second episode of redness the size of two quarters appeared and lasted for a couple of days.  That redness it subsided for a day. Then the  redness returned is about the size of the palm of patient's  hand. It is not a bright red or itchy and doesn't look like a rash. In addition, patient reports developing a nodule at the collarbone on her left side two days after the vaccine. Patient reports no fever or other symptoms. At Clinic visit, provider notes that all of the patient's symptoms are resolving.
Per patient's daughter, site of administration swollen and painful. Onset 1-2 hours post vaccination, via F/U with PCP or ER visit.
Patient stated that the day after receiving her flu shot she had bad muscle aches and and body pain. She stated that at around 8:30am that morning, she tried to eat and began projectile vomiting. She also had a severe headache and felt like she couldn't catch her breath at times. At 11:00am she was able to fall asleep, woke up again at 1:00pm and vomited and then around 5:00pm she started to feel better. She stated that the next morning she felt great. Offered patient follow up in our office but patient stated that she did not need it at this time.
I woke up the bottom right side of my face was numb, and my bottom lip is still numb, not like it was but it still is. I ended up loosing 3 teeth.
A non-serious spontaneous report of facial edema has been received from a physician concerning a 17-year-old female, subsequent to FLUMIST. Neither relevant medical history nor concomitant medications have been reported for this patient. The patient received a dose of FLUMIST on 27-Oct-2010. On 07-Nov-2010, the patient developed facial edema. The patient had been seen in the physicians office on 09-Nov-2010 and 12-Nov-2010 for the facial swelling. The outcome of the event facial edema was unknown.
My face started to have a burning sensation and very flush. It started on both cheeks around 4 pm on  11/11/21. From then it has spread throughout my entire face. And still present as of today 11/12/21 at 11:42am
(Written next day) Patient stated that shortly after receiving the vaccine approximately 30-60 min minutes later she started to feel swelling in her face as well as her lips. She took a photo of this and showed it to me today and well. The swelling around the eyes seemed minimal. Her lips were swollen. She also notes that she felt tired and had a mild shortness of breath where she felt more comfortable sitting up. She states these symptoms have somewhat improved, though she has been experiencing increasing nausea since yesterday and continues to feel that way. She states that she does not believe she is pregnant, she has an IUD. She also noticed some body aches yesterday, continuing this morning, but they seem to be improving. They do improve greatly with ibuprofen at home.
Case number PHEH2014US002079 is an initial spontaneous report received from a nurse on 27 Jan 2014 with a follow-up received on 25 Feb 2014. This report refers to a 3-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with 0.5 ml of FLUVIRIN, (batch number: 13462P, expiry date: May 2014) intramuscularly into right deltoid on 20 Jan 2014. Nurse reported that the patient under 4 years of age received FLUVIRIN. No adverse event was reported following medication error. Follow up received from health care professional on 25 Feb 2014: Site of vaccination and reporter details updated.
102 degree fever lasting 24 hours, rash at injection site, up and down arm, around neck area  and upper chest area.
Received two vaccines on the 11th of July 2006 in the afternoon.  One was a Tetanus and Diphtheria (Td) VACCINE, in my left arm, and the 2nd shot was a Pneumococcal polysaccharide (PPV) vaccine given in my right arm.  I had developed soreness and a knot in my arm but was advised that this would probably occur by the doctor.  On the evening of 07/17/2006, approximately 11 pm or so, I experienced additional pain and horrible itching on my left arm, examined my arm and noticed an extremely large hive at the shot site.  My arm was hot to the touch and more painful than before.  I called the doctor office the next day (07/18/2006) and made an appointment to be seen that same afternoon.  Was seen by facility and administer medication.  I had to take off work that afternoon in order to go to the doctor's office, as well as incurring additional expenses for the office visit and prescription received, all due to the allergic reaction suffered by this Tetanus vaccine.
Cellulitis vs local vaccine reaction (L) femoral lateral. Rx cephalexin x 10 days.
pain; aches in body/muscle pain; Slight Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain), MYALGIA (aches in body/muscle pain) and HEADACHE (Slight Headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013620A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN (pain), MYALGIA (aches in body/muscle pain) and HEADACHE (Slight Headache). At the time of the report, PAIN (pain), MYALGIA (aches in body/muscle pain) and HEADACHE (Slight Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
CHILLS, COUGHING, HEADACHE, BODY ACHES, HANDS AND ARMS FELT LIKE THEY WERE ON FIRE, JAWS STARTED LOCKING UP, SINUS.
For 1 hour post injection, metallic taste in mouth. Beginning 6 hours later: myalgias, fatigue, fever -> resolved at 30 hours post vaccine.
I contracted COVID-19 on 05/15/2022 with symptoms of chills, myalgia, fatigue, congestion, slight cough, and runny nose. I was not prescribed any medications and was told to treat my symptoms with over the counter medications. I was ill for 5 to 7 days before symptoms abated. I do not have any lingering symptoms and I am fully recovered.
Increased back pain; Felt nauseous, never threw up; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Increased back pain) and NAUSEA (Felt nauseous, never threw up) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Back pain, Fish allergy and Seafood allergy (Allergy to shrimp).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced BACK PAIN (Increased back pain) and NAUSEA (Felt nauseous, never threw up). In January 2021, NAUSEA (Felt nauseous, never threw up) had resolved. At the time of the report, BACK PAIN (Increased back pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used includes epidurals. This patient is seen by a Orthopedic doctor for his history of back pain. Treatment information was not provided.   Reporter did not allow further contact
improperly stored vaccines administered to patients; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On 08-SEP-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX)  lot # T006346, expiration date 20-FEB-2022 (dose, route and frequency were not reported) for prophylaxis.  The reporter stated that the excursion occurred between 01-SEP-2021 and 09-SEP-2021; as the vaccines were stored in the freezer and got too warm and they did not realize that the freezer was "going in and out of range" (temperature of excursion and duration of excursion were not reported). Also, the reporter mentioned that the remaining vaccines were back in the recommended temperature range but she did not have information needed to evaluate at the reporting time.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2109USA002915:Original Case : 2109USA002915
Facial numbness which began 17-18 minutes after the injection. Tingling/numbness in jaw area, from  ears to chin on both sides. Lasted only a minute or two and went away. Face has continued to feel flushed for 2 hours since. No other reaction.
Swelling at vaccination site beginning  about 3.5 hours post vaccination. Morning of 10/17/2021, swelling of left axillary lymph node, currently ongoing
she was losing her voice; malaise/not feeling well; injection site pain; Muscle ache; Fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID:.  A 69-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 20Sep2023 at 15:00 as dose 6 (booster), 0.3 ml single (Batch/Lot number: unknown) at the age of 69 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunization; Bnt162b2 (Dose 2), for COVID-19 immunization; Bnt162b2 (Dose 3 (Booster)), for COVID-19 immunization; Bnt162b2 (Dose4 (Booster)), for COVID-19 immunization; Bnt162b2;bnt162b2 omi ba.4-5 (Dose 5 (Booster) ), administration date: Oct2022, for COVID-19 immunization. The following information was reported: FATIGUE (non-serious) with onset 20Sep2023, outcome "not recovered"; MYALGIA (non-serious) with onset 20Sep2023, outcome "recovering", described as "Muscle ache"; VACCINATION SITE PAIN (non-serious) with onset 20Sep2023, outcome "recovering", described as "injection site pain"; MALAISE (non-serious) with onset 20Sep2023, outcome "recovering", described as "malaise/not feeling well"; APHONIA (non-serious) with onset 22Sep2023, outcome "unknown", described as "she was losing her voice". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Caller (patient is his wife) mentioned that a family member who received a Pfizer Covid vaccine is not feeling well and got worse the next day. His wife and he got the Pfizer COVID-19 vaccine on Wednesday (20Sep2023). Caregiver on the line calling about his wife got Covid-19 Vaccine and she experienced symptoms, malaise, injection site pain, and the next day got worse. So she had chills something like the flu. She got this vaccine on Wednesday. Yesterday evening they test themselves for Covid, caller was negative, but wife was positive for covid after getting the vaccine. Patient had total previous 5 doses Pfizer Covid Vaccines. The last one given was the Bivalent Vaccine in Oct 2022.   The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I ready got my vaccine on June 16) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I ready got my vaccine on June 16). On 16-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I ready got my vaccine on June 16) had resolved. No concomitant medications were reported. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Moderna vaccine dose 2 details added and event 'Missed dose' was changed to 'Inappropriate schedule of drug administration.
I had chest and back pains around my heart area. They were mild but noticeable. It would come and go. I would also have a little bit of shallow breath sometimes. It stopped about 2 ½ weeks after. It was on and off for that time. I went to my doctor regarding this and all tests were normal.
Red face and chest pain started on 2/9/2021. Resolved by 2/10/2021.
Vaccine was  administered beyond use date of the product by a handful of days. No  adverse effects were reported.
Patient received vaccine in the counseling room, he waited about 5 minutes in the room. he vacated the room for another incoming vaccine and continued to wait in front of the pharmacy. after 5 more minutes he got up to alert us that he wasn't feeling well as I saw him get up I rushed out to catch him but he already softly fell to the floor and seemed to be disoriented. My partner pharmacist lifted his head off the ground into her lap. I asked to put his feet up but was not oriented enough to understand my request. I move his feet closer to his body and asked another technician to keep holding them while we got him an ice pack that we placed on his forehead. at this point he was alert enough to say that it was comfortable on his forehead. we got him some called water to drink which he did in a few short minutes. he wanted to stay laying down for a while longer.  he stated he had eaten lunch but it had been awhile since then . We asked him if he would some orange juice and declined.  he stated that he doesn't need an EMS. he came alone and declined us calling a family member to assist him.  He left as he felt much better.  We explained that this is a possible effect of many shots and not particular to Covid  vaccine. He confirmed that he'll see us back for his second shot.
Patient complained of difficulty swallowing which subsided spontaneously in < 1 minute.   Patient observed x 40 minutes. No SOB or further complaints.  BP 119/73   HR 84  Sat 100%
Shingles; Fading rash; Neuralgic pain; Patient did not received 2nd dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of shingles in a 67-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included chickenpox (had 5 pox as a child).   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles (Verbatim: Shingles), rash (Verbatim: Fading rash), post herpetic neuralgia (Verbatim: Neuralgic pain) and incomplete course of vaccination (Verbatim: Patient did not received 2nd dose). The outcome of the shingles was resolving and the outcome of the rash and post herpetic neuralgia were not resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the shingles, rash and post herpetic neuralgia to be related to Shingrix.     It was unknown if the company considered the shingles, rash and post herpetic neuralgia to be related to Shingrix.   Additional Information: GSK Receipt Date: 17-MAY-2023 The patient reported that he or she received first dose of Shingrix vaccine few years ago and did not received second dose. The patient stated that he or she just recovering from shingles and still have fading rash and neuralgic pain. The physician told her to repeat the two dose series. The patient wanted to know how long after the rash heals and should he or she wait before repeating the two series vaccine. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix vaccine, which led to incomplete course of vaccination. The reporter did consent to follow up.
could not sleep that evening, ran a temperature of 102 for most of the next day, chills, ongoing headache; fever broke about 8 p.m. next day
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 02-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used).    No concomitant medication were reported.  Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date.  No treatment medication were reported.    Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up document contains no additional information.
Cryptogenic stroke of the right medulla. Hospitalized, given stroke protocol appropriate medications. No permanent debilitation expected due to location of stroke.